文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

美国Y群脑膜炎奈瑟菌中β-内酰胺酶阳性分支获得环丙沙星耐药

Acquisition of Ciprofloxacin Resistance Among an Expanding Clade of β-Lactamase-Positive, Serogroup Y Neisseria meningitidis in the United States.
PubMed 文献 · Clin Infect Dis · 2021-01-01

研究分析了2011年1月至2020年2月美国人口监测收集的2097株脑膜炎奈瑟菌基因组,发现2018年12月后出现11株青霉素和环丙沙星双耐药菌株,均为Y群ST3587 CC23,含blaROB-1和gyrA T91I突变。所有33株blaROB-1阳性美国分离株形成单一分支,提示β-内酰胺酶阳性菌株获得环丙沙星耐药。

要点

  • 2018年12月后美国出现11株Y群脑膜炎奈瑟菌对青霉素和环丙沙星双耐药。
  • 双耐药菌株均含blaROB-1和gyrA T91I突变,属ST3587 CC23。
  • 所有33株blaROB-1阳性美国分离株形成单一分支,提示克隆传播。

核心结论

  • 美国近期出现的Y群脑膜炎奈瑟菌双耐药病例提示抗菌药物耐药模式正在变化。
  • 双耐药源于含β-内酰胺酶的脑膜炎奈瑟菌获得了环丙沙星耐药。
  • 常规抗菌药物耐药监测可有效监测耐药变化和传播。

研究设计与样本

  • 研究分析了2011年1月至2020年2月美国人口监测收集的2097株脑膜炎奈瑟菌基因组。
  • 鉴定由blaROB-1或gyrA介导耐药的菌株,并进行表型确认。
  • 将美国分离株基因组与含blaROB-1的非美国分离株基因组进行比较。
  • 通过比较奈瑟菌属物种间的gyrA评估环丙沙星耐药的种间转移。

主要发现

  • 2018年12月后鉴定出11株青霉素和环丙沙星耐药分离株,均为Y群、ST3587、CC23,含blaROB-1和含T91I的gyrA等位基因。
  • 2013年至2020年还鉴定出22株青霉素耐药、含blaROB-1但gyrA为野生型的美国分离株。
  • 所有33株含blaROB-1的分离株与来自其他6个国家的12株含blaROB-1分离株形成单一分支。
  • 含blaROB-1的美国分离株中三分之二来自西班牙裔个体。
  • 另鉴定出12株含gyrA T91突变的环丙沙星耐药分离株,属于6个CC,含10种独特gyrA等位基因,其中7种与乳糖奈瑟菌或淋病奈瑟菌的等位基因相似或相同。

临床怎么用

  • 对侵袭性脑膜炎球菌病病例应关注青霉素和环丙沙星耐药,尤其是Y群ST3587 CC23。
  • 常规抗菌药物耐药监测有助于及时发现耐药变迁和传播。
  • 环丙沙星耐药可能通过种间转移获得,需关注奈瑟菌属间的耐药传播。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Penicillin and ciprofloxacin are important for invasive meningococcal disease (IMD) management and prevention. IMD cases caused by penicillin- and ciprofloxacin-resistant Neisseria meningitidis containing a ROB-1 β-lactamase gene (blaROB-1) and a mutated DNA gyrase gene (gyrA) have been recently reported in the United States. METHODS: We examined 2097 meningococcal genomes collected through US population-based surveillance from January 2011 to February 2020 to identify IMD cases caused by strains with blaROB-1- or gyrA-mediated resistance. Antimicrobial resistance was confirmed phenotypically. The US isolate genomes were compared to non-US isolate genomes containing blaROB-1. Interspecies transfer of ciprofloxacin resistance was assessed by comparing gyrA among Neisseria species. RESULTS: Eleven penicillin- and ciprofloxacin-resistant isolates were identified after December 2018; all were serogroup Y, sequence type 3587, clonal complex (CC) 23, and contained blaROB-1 and a T91I-containing gyrA allele. An additional 22 penicillin-resistant, blaROB-1- containing US isolates with wild-type gyrA were identified from 2013 to 2020. All 33 blaROB-1-containing isolates formed a single clade, along with 12 blaROB-1-containing isolates from 6 other countries. Two-thirds of blaROB-1-containing US isolates were from Hispanic individuals. Twelve additional ciprofloxacin-resistant isolates with gyrA T91 mutations were identified. Ciprofloxacin-resistant isolates belonged to 6 CCs and contained 10 unique gyrA alleles; 7 were similar or identical to alleles from Neisseria lactamica or Neisseria gonorrhoeae. CONCLUSIONS: Recent IMD cases caused by a dual resistant serogroup Y suggest changing antimicrobial resistance patterns in the United States. The emerging dual resistance is due to acquisition of ciprofloxacin resistance by β-lactamase-containing N. meningitidis. Routine antimicrobial resistance surveillance will effectively monitor resistance changes and spread.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Potts CC, Retchless AC, McNamara LA, et al. Acquisition of Ciprofloxacin Resistance Among an Expanding Clade of β-Lactamase-Positive, Serogroup Y Neisseria meningitidis in the United States. Clin Infect Dis. 2021. PMID: 33900407. doi:10.1093/cid/ciab358

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。